Listed

Arbutus Biopharma Corp

ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31

Reports and events: 561 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Arbutus Biopharma Corp, Reports and events
FiledFormWhat it isAccession number
2015-06-1908:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-003522
2015-06-1808:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-003493
2015-05-2916:40 ETDEF 14AProxy statementPeriod 2015-07-090001171843-15-003209
2015-05-2117:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-003017
2015-05-0617:25 ET10-QQuarterly reportPeriod 2015-03-310001171843-15-002592
2015-05-0616:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-15-002575
2015-05-0116:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-002425
2015-05-0117:31 ET10-K/AAnnual report, amendedPeriod 2014-12-310001171843-15-002398
2015-04-2319:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-002119
2015-04-2215:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-002109
2015-04-1008:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-001910
2015-03-2619:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-001649
2015-03-2513:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-15-104674
2015-03-2013:31 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-15-099914
2015-03-1817:21 ET8-K/A9.01 Financial statements and exhibits0001193125-15-097140
2015-03-1816:56 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-001484
2015-03-1808:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-001473
2015-03-1617:21 ETSC 13DOwnership report, active investor0001193125-15-094048
2015-03-1617:16 ETSC 13DOwnership report, active investor0001144204-15-016449
2015-03-1316:18 ET10-KAnnual reportPeriod 2014-12-310001171843-15-001398
2015-03-1215:56 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-15-001373
2015-03-1113:54 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-001349
2015-03-0617:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-001302
2015-03-0619:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-001291
2015-03-0619:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-001290
2015-03-0417:00 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001171843-15-001260
2015-02-2616:44 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-001105
2015-02-1217:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-000784
2015-02-1117:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-000752
2015-02-0514:26 ET8-K5.01 Change in control; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-000630
2015-01-2817:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-000394
2015-01-2616:48 ET8-K/A1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001171843-15-000358
2015-01-2108:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-000285
2015-01-1217:26 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-000197
2014-12-3109:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-006074
2014-12-2209:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-006000
2014-12-2208:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-005999
2014-12-1914:28 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-005977
2014-11-2817:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-005717
2014-11-2421:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-005656
2014-11-1708:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-005578
2014-11-1319:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-005479
2014-11-0720:45 ET10-QQuarterly reportPeriod 2014-09-300001171843-14-005345
2014-11-0615:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-14-005325
2014-11-0619:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-005274
2014-10-2419:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-004942
2014-10-2219:56 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-004877
2014-10-1515:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-004780
2014-10-1406:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-004716
2014-10-0913:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-14-004689

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.